Feng Wu

TL;DR: In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically significant clinical benefits, however, the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies.

TL;DR: Examination of the relationship between fasting blood glucose (FBG) and 28-day mortality in coronavirus disease 2019 (COVID-19) patients not previously diagnosed as having diabetes found that FBG ≥7.0 mmol/l at admission is an independent predictor for 28- day mortality in patients with CO VID-19 without previous diagnosis of diabetes.

TL;DR: In this article, the authors present a brief background information of nanoparticles as drug carriers, including but not limited to the types of nanomaterials, their biological properties and their advantages in clinical application.

TL;DR: The initial experience with TMPs-MTX in advanced lung cancer with MPE suggests that ATMPs targeting malignant cells and the immunosuppressive microenvironment may be a promising therapeutic platform for treating malignancies.

TL;DR: This review focuses on recent experimental and clinical studies investigating the basic properties, roles, and mechanisms of ACE2, Ang-(1–7), and the MasR, as well as the axis pathway, to provide insights into possible therapeutic strategies for treating cancer that target the ACE2/Ang-(1-7)/MasR axis.